He received his Ph.D. from the University of Victoria, Canada. And conducted his post-doctoral work at the University of Alberta, Canada. Dr. Brooks is interested in using X-ray crystallography and protein engineering to better understand how antibodies interact with their targets. Dr. Brooks’ lab is exploring the ability of single domain antibodies (nanobodies) to neutralize the food pathogen Listeria, and engineering therapeutic antibodies to bind the cancer associated protein MUC1.